載入...
Aromatase and CDK4/6 Inhibitor-Induced Musculoskeletal Symptoms: A Systematic Review
SIMPLE SUMMARY: Aromatase inhibitor-induced musculoskeletal symptoms (AIMSS) occurs in up 50% of postmenopausal patients and is the reason for treatment discontinuation in 25% of patients with breast cancer. CDK4/6 inhibitors have been established in the treatment of hormone receptor-positive (HR) b...
Na minha lista:
| 發表在: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7865932/ https://ncbi.nlm.nih.gov/pubmed/33530456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030465 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|